Showing studies matching your search3 results shown
Studies (3 shown)
NCT04802759PHASE1, PHASE2RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Sponsor · Hoffmann-La RocheCondition · Inoperable, Locally Advanced or Metastatic, ER-positive Breast CancerIntervention · Giredestrant, AbemaciclibUpdated May 2026
NCT06790693PHASE3RECRUITING
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Sponsor · Hoffmann-La RocheCondition · Breast CancerIntervention · Inavolisib, PlaceboUpdated May 2026
NCT07323576PHASE2WITHDRAWN
A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer
Sponsor · Hoffmann-La RocheCondition · Colorectal CancerIntervention · Inavolisib, BevacizumabUpdated Feb 2026
Showing top 3 results. See all 3 results on CT.gov →